A 60-word provision in House Speaker Nancy Pelosi's drug-pricing plan could make it impossible for hospitals to get a 340B discount for any drug that Medicare negotiates for, according to STAT.
Pharmacy
Pfizer's executive chairman Ian Read will retire at the end of the year, according to The Wall Street Journal.
Avanir Pharmaceuticals agreed to pay $116 million to settle a lawsuit alleging it illegally marketed its drug Nuedexta, according to STAT.
CMS plans to collect pricing and payment information from hospitals participating in the 340B drug discount program, according to a notice issued Sept. 26.
Mylan agreed to pay $30 million to settle a lawsuit claiming it failed to disclose to investors a 2017 U.S. Justice Department probe into whether it overcharged Medicaid for its EpiPen allergy treatment.
Advertisement
Seven drugs approved by the FDA since Aug. 19:
The FDA approved the first treatment for children with rare vasculitis diseases that cause inflammation of blood vessels and reduce blood flow to organs.
St. Mary's Medical Center started a program called "meds-to-beds" several years ago to give patients better access to prescriptions, according to The Intelligencer.
Drugmaker Novo Nordisk's newly approved oral diabetes treatment will cost $772 per month, according to Investor's Business Daily.
Discount retail and pharmacy chain Fred's reached deals with Walgreens Boots Alliance and ExpressRx to sell some of its pharmacy assets, according to The Wall Street Journal.